Sanofi-Aventis CEO: To Budget HIV Vaccine R&D In '10
PARIS -(Dow Jones)- French drug company Sanofi-Aventis SA (SNY) will set aside funds in its 2010 research and development budget to develop an HIV vaccine, Chief Executive Christopher Viehbacher said Thursday.
"We'll put the means necessary" to create a vaccine, he told reporters at a press conference on the results of a phase III trial for an HIV vaccination.
He noted the phase III trial presented Thursday was funded by the U.S. government and not Sanofi. Sanofi's investments were in developing the vaccine, he said.
"I don't want to hear we can't move forward because there's no budget," he said, without specifying how much he thought the company would set aside.
-By Mimosa Spencer, Dow Jones Newswires; +33 1 4017 1740; email@example.com
(END) Dow Jones Newswires
September 24, 2009 11:48 ET (15:48 GMT)
Copyright (c) 2009 Dow Jones & Company, Inc.
|aus der Diskussion:||Sanofi-Aventis meldet ersten Erfolg aus Studie zu HIV-Impfstoff|
|Autor (Datum des Eintrages):||Poppholz (25.09.09 10:46:19)|
|Beitrag:||22 von 27 (ID:38055192)|
|Alle Angaben ohne Gewähr © wallstreet:online|